Revital.co.uk Currently Unavailable? Where to Buy the Original De Simone Probiotic in the UK

Based on public records as of May 2026, Revital.co.uk is password-protected and directing customers to Bailey Ahmad Business Recovery (BABR), a firm of insolvency practitioners. Two creditors' meeting notices were published in the London Gazette in April 2026 relating to Revital Limited — one for nomination of a liquidator (Notice 5108823, 9 April 2026) and one for a proposed joint liquidator appointment that was subsequently cancelled due to a change of circumstances (Notice 5119570, 23 April 2026). Companies House still lists the company as Active as of 4 May 2026. The precise legal status under insolvency law has not been independently confirmed beyond these public notices.

CDS22-formula is marketed by its manufacturer as containing the original De Simone Formulation — the specific 8-strain, 450 billion CFU blend developed by Professor Claudio De Simone that was associated with the VSL#3 brand prior to 2016. Following a brand and ownership dispute in 2016, the VSL#3 name passed to a new commercial entity that reformulated the product. The pre-2016 clinical trials — including Kim et al. (Alimentary Pharmacology & Therapeutics, 2003) and Gionchetti et al. (Gastroenterology, 2000) — used the original De Simone Formulation composition that CDS22-formula is marketed as containing. The post-2016 VSL#3 product is a different commercial formulation and those pre-2016 trial results should not be attributed to it.

Vivomixx was the European commercial name for the original De Simone Formulation probiotic following the 2016 VSL#3 brand dispute. The product was sold under the Vivomixx name in European markets while the formulation rights dispute was resolved. The same formulation is now marketed globally as CDS22-formula. It is available in the UK from Probiotic.co.uk with next-day DPD cold-chain delivery. The Vivomixx brand name is no longer in active commercial use in the UK market.

We cannot verify that Revital Limited is legally bankrupt. Public records show Revital.co.uk is currently password-protected, customers with unfulfilled orders are directed to Bailey Ahmad Business Recovery (BABR) at revital@babr.co.uk, and two Gazette creditors' meeting notices were published in April 2026. Gazette Notice 5108823 (9 April 2026) confirmed a creditors' meeting was convened to decide on nomination of a liquidator. Gazette Notice 5119570 confirmed a virtual meeting had been called with the intention of appointing joint liquidators, but that the meeting was cancelled due to a change of circumstances. Companies House still lists Revital Limited as Active as of 4 May 2026.

Yes. Revital.co.uk is currently password-protected and inaccessible to customers as of May 2026. The site displays a message directing customers with unfulfilled orders to email revital@babr.co.uk with their order number and details. Status last verified: 4 May 2026.

Revital.co.uk is password-protected and inaccessible to the public. Gazette Notice 5108823 (9 April 2026) confirmed a creditors' meeting was convened for the purpose of deciding on nomination of a liquidator. Gazette Notice 5119570 confirmed a virtual meeting had been called with the intention of appointing joint liquidators, but that the meeting was cancelled due to a change of circumstances. Bailey Ahmad Business Recovery (BABR) are named in the Gazette notices and on the Revital password page as the contact point for customer enquiries. Companies House still lists Revital Limited as Active as of 4 May 2026. Companies House status can lag behind Gazette insolvency notices and should be read alongside the public notices.

We cannot verify that Revital Limited is legally bankrupt. Gazette Notice 5108823 (9 April 2026) confirmed a creditors' meeting was convened for the purpose of deciding on nomination of a liquidator. Gazette Notice 5119570 confirmed a virtual meeting had been called with the intention of appointing joint liquidators, but that the meeting was cancelled due to a change of circumstances. Companies House still lists Revital Limited (Company No. 02570370) as Active as of 4 May 2026. Companies House status can lag behind Gazette insolvency notices and should be read alongside the public notices.

CDS22-formula, available from Probiotic.co.uk, is the UK-available continuation of the original De Simone Formulation — the same 8-strain, 450 billion CFU composition previously sold as VSL#3 (pre-2016) and as Vivomixx in Europe. Probiotic.co.uk is the authorised UK distributor with next-day DPD cold-chain delivery. For full formulation history see vsl3-alternative-uk and vivomixx-alternative-uk.

CDS22-formula is the closest UK alternative to Vivomixx. Vivomixx was the European commercial name for the original De Simone Formulation after the 2016 VSL#3 brand dispute. That same 8-strain, 450 billion CFU formulation is now sold as CDS22-formula, available from Probiotic.co.uk with next-day UK delivery.

CDS22-formula contains the original De Simone Formulation — the specific 8-strain, 450 billion CFU blend developed by Professor Claudio De Simone. This is the same composition used in pre-2016 VSL#3 clinical trials and sold in Europe as Vivomixx. The post-2016 VSL#3 product uses a different formulation and is a separate product.

Contact your payment provider immediately — bank, credit card, or PayPal — to raise a chargeback claim. For credit card purchases over £100, Section 75 of the Consumer Credit Act 1974 makes the card issuer jointly liable. Chargeback deadlines are commonly 120 days, but the exact start date depends on your card scheme and circumstances — contact your provider without delay. You can also email revital@babr.co.uk with your order number to register with the insolvency practitioners directly.

Probiotic.co.uk ships CDS22-formula with next-day DPD tracked delivery, Monday to Thursday only. All orders are packed with cold-chain insulation and an ice pack. No Friday dispatch — this avoids the product sitting in a depot over a weekend. Shelf-stable for 7 days in transit. Refrigerate on arrival and store below 8°C.

CDS22-formula contains the original De Simone Formulation studied in multiple peer-reviewed RCTs across conditions including irritable bowel syndrome (IBS), ulcerative colitis (UC), and pouchitis. Kim et al. (Alimentary Pharmacology & Therapeutics, 2003) found a statistically significant reduction in IBS bloating (p=0.046). Gionchetti et al. (Gastroenterology, 2000) reported 85% remission maintenance in chronic pouchitis vs 0% placebo. Kim et al. (Neurogastroenterology & Motility, 2005) found significant reduction in flatulence in IBS patients (p=0.011). All trials used the 8-strain, 450 billion CFU De Simone Formulation composition — the same composition CDS22-formula is marketed as containing. CDS22-formula is a food supplement, not a medicine, and is not intended to treat or cure any condition.